Vis enkel innførsel

dc.contributor.authorSkov, Jakob
dc.contributor.authorKuja-Halkola, Ralf
dc.contributor.authorMagnusson, Patrik K.E.
dc.contributor.authorGudbjörnsdottir, Soffia
dc.contributor.authorKämpe, Olle
dc.contributor.authorBensing, Sophie
dc.date.accessioned2022-09-27T12:12:37Z
dc.date.available2022-09-27T12:12:37Z
dc.date.created2022-09-20T13:33:04Z
dc.date.issued2022
dc.identifier.issn0804-4643
dc.identifier.urihttps://hdl.handle.net/11250/3021794
dc.description.abstractObjective Type 1 diabetes and Hashimoto’s thyroiditis frequently cluster in individuals and in families, indicating shared origins. The objective of this study was to investigate familial co-aggregation of these diseases and to quantify shared genetic and environmental factors. Design This study is a twin cohort study. Methods National health registers were used to identify cases among 110 814 Swedish twins. Co-aggregation was calculated as risk ratios for type 1 diabetes among co-twins of individuals with Hashimoto’s thyroiditis, and vice-versa. Variance explained by genetics (i.e. heritability), and the proportions thereof shared between the diseases, was estimated by contrasting associations in monozygotic and dizygotic twins using structural equation models. Results Individuals with one disease were at a high risk for the other disease (adjusted risk ratio: 11.4 (95% CI: 8.5–15.3)). Co-aggregation was more common in monozygotic than in dizygotic pairs, with adjusted risk ratios of 7.0 (95% CI: 3.2–15.1) and 1.7 (95% CI: 0.7–4.1), respectively. Genetic effects shared across diseases accounted for 11% of the variance for type 1 diabetes and 9% of the variance for Hashimoto’s thyroiditis, while environmental factors unique to individual twins, but shared across diseases, accounted for 10% of the variance for type 1 diabetes and 18% of the variance for Hashimoto’s thyroiditis. Conclusions Both genes and environment unique to individual twins contribute to considerable etiologic overlap between type 1 diabetes and Hashimoto’s thyroiditis. These findings add to the current knowledge on the mechanisms behind autoimmune disease clustering and could guide future research aimed at identifying pathophysiological mechanisms and intervention targets.en_US
dc.language.isoengen_US
dc.publisherBioScientificaen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleShared etiology of type 1 diabetes and Hashimoto’s thyroiditis: a population-based twin studyen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2022 The Authorsen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doi10.1530/EJE-22-0025
dc.identifier.cristin2053549
dc.source.journalEuropean Journal of Endocrinology (EJE)en_US
dc.source.pagenumber677-685en_US
dc.identifier.citationEuropean Journal of Endocrinology. 2022, 186 (6), 677-685.en_US
dc.source.volume186en_US
dc.source.issue6en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal